RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,338,000 | +61.8% | 1,184,700 | +278.6% | 0.02% | +100.0% |
Q4 2021 | $827,000 | -15.6% | 312,900 | +15.9% | 0.01% | -25.0% |
Q3 2021 | $980,000 | -49.3% | 270,000 | -39.3% | 0.01% | -53.8% |
Q2 2021 | $1,932,000 | +1023.3% | 445,000 | +790.0% | 0.03% | +550.0% |
Q1 2021 | $172,000 | – | 50,000 | +24900.0% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 200 | -99.9% | 0.00% | -100.0% |
Q3 2020 | $336,000 | +166.7% | 140,000 | +154.5% | 0.01% | -20.0% |
Q4 2018 | $126,000 | – | 55,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |